Just as the patent is about to run out for Prozac, we learn that this worldwide topselling antidepressant isn’t any more effective than its competitors, Paxil and Zoloft. These three popular antidepressants, all from the same drug class, called selective serotonin reuptake inhibitors (SSRIs), were shown to be of similar effectiveness in a new study published in the Journal of the American Medical Association (JAMA, 12/19/01).
[more]
Posted August 21st, 2007 | No Comments